The Official Website of the Long-Term Investor
Results 121 - 128 of 128 : Previous 5 6 7 8 9 10 11 12 13
Get 'em fresh from the oven.
Biotech firm Celgene reports its 2006 financial results and provides an update for its 2007 guidance.
Celgene Looks Stellar: Fool by Numbers
Fast facts the Fool way.
Celgene Faces a Generic Challenge
Barr wants to market a version of Thalomid, Celgene's top drug.
The pharmaceutical company racks up bountiful sales.
A Healthy Celgene: Fool by Numbers
Fast facts the Fool way.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK